Literature DB >> 16145175

Molecular evidence of recurrent histoplasmosis with 9-year latency in a patient with Addison's disease.

Tai-Chung Tseng1, Shwu-Jen Liaw, Cheng-Hsiang Hsiao, Cheng-Yi Wang, Li-Na Lee, Tien-Shang Huang, Po-Ren Hsueh.   

Abstract

We present a case of fatal histoplasmosis in a patient with Addison's disease and long-term use of corticosteroid. The patient acquired Histoplasma capsulatum in China and initially presented with a laryngeal mass. He developed fulminant pneumonia and respiratory failure 9 years later. Nucleotide sequences of internal transcribed spacer regions of rRNA genes of the H. capsulatum isolate recovered from biopsied lung tissue and of the extracted fungal DNA from the laryngeal lesion were identical, indicating the recurrent nature of infection.

Entities:  

Mesh:

Substances:

Year:  2005        PMID: 16145175      PMCID: PMC1234113          DOI: 10.1128/JCM.43.9.4911-4913.2005

Source DB:  PubMed          Journal:  J Clin Microbiol        ISSN: 0095-1137            Impact factor:   5.948


  14 in total

1.  Reactivation of histoplasmosis after treatment with infliximab.

Authors:  Masha Nakelchik; Julie E Mangino
Journal:  Am J Med       Date:  2002-01       Impact factor: 4.965

2.  Chronic infection and reactivation in a pulmonary challenge model of histoplasmosis.

Authors:  M Durkin; S Kohler; C Schnizlein-Bick; A LeMonte; P Connolly; J Goldberg; T Garringer; L J Wheat
Journal:  J Infect Dis       Date:  2001-05-16       Impact factor: 5.226

3.  Recurrent colonic histoplasmosis after standard therapy with amphotericin B in a patient with Job's syndrome.

Authors:  M S Cappell; N C Manzione
Journal:  Am J Gastroenterol       Date:  1991-01       Impact factor: 10.864

4.  Recurrent histoplasmosis of the wrist: a case report.

Authors:  S B Care; S H Lacey
Journal:  J Hand Surg Am       Date:  1998-11       Impact factor: 2.230

5.  Microbiologic and histologic diagnosis of histoplasmosis in Taiwan.

Authors:  T W Kao; C C Hung; P R Hsueh; T Y Lin; M Y Chen; K T Luh; C Y Chuang
Journal:  J Formos Med Assoc       Date:  1997-05       Impact factor: 3.282

6.  [Recurrent chronic buccopharyngeal histoplasmosis developing for 13 years. Successive treatments with amphotericin B].

Authors:  E Drouchet; B Sureau; J Berrod
Journal:  Bull Soc Pathol Exot Filiales       Date:  1968

7.  Clinicopathologic study of Kaposi's sarcoma and strain analysis of human herpesvirus 8 (HHV-8) DNA in the Hua-Lien area of eastern Taiwan.

Authors:  Y H Hsu; W L Kuo; I J Su
Journal:  J Formos Med Assoc       Date:  2001-07       Impact factor: 3.282

8.  Repeatedly relapsing disseminated histoplasmosis: clinical observations during long-term follow-up.

Authors:  C V Paya; P E Hermans; R E Van Scoy; R E Ritts; H A Homburger
Journal:  J Infect Dis       Date:  1987-08       Impact factor: 5.226

9.  Recurrent disseminated histoplasmosis.

Authors:  R J Morris; R F Betts; R G Douglas; R F Jacox
Journal:  South Med J       Date:  1978-06       Impact factor: 0.954

10.  Prevention of relapse of histoplasmosis with fluconazole in patients with the acquired immunodeficiency syndrome.

Authors:  S Norris; J Wheat; D McKinsey; D Lancaster; B Katz; J Black; M Driks; R Baker; K Israel; D Traeger
Journal:  Am J Med       Date:  1994-06       Impact factor: 4.965

View more
  3 in total

Review 1.  How Environmental Fungi Cause a Range of Clinical Outcomes in Susceptible Hosts.

Authors:  Steven T Denham; Morgan A Wambaugh; Jessica C S Brown
Journal:  J Mol Biol       Date:  2019-05-09       Impact factor: 5.469

2.  Chronic cavitary pulmonary histoplasmosis in a non-HIV and immunocompromised patient without overseas travel history.

Authors:  Eun Ju Jung; Dae Won Park; Jung-Woo Choi; Won Suk Choi
Journal:  Yonsei Med J       Date:  2015-05       Impact factor: 2.759

3.  Localized Histoplasma capsulatum osteomyelitis of the fibula in an immunocompetent teenage boy: a case report.

Authors:  Lu Huang; Yongping Wu; Xudong Miao
Journal:  BMC Infect Dis       Date:  2013-03-11       Impact factor: 3.090

  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.